BDP1 and breast carcinoma: Specifically, Professor Laura Schramm pointed out that our article miscited Gensler’s study entitled “Negative Regulation of HER2 Signaling by the PEST-type Protein-tyrosine Phosphatase BDP1” as evidence for the TFIIIIB-associated BDP1 subunit playing a pivotal role in breast cancer.